Batch 001 - Live Allocation

Q4 launch pricing · ends 31 Dec

Vivre Labs

Institutional Longevity

Catalogue
Single-vial Blends · one injection
Clinical Details

- Peptides -

- Single-vial Blends -

- Goals -

- Clinical Reference -

- Guides -

- Integrity -

◇ Compound Reference

REPRODUCTIVE PEPTIDEInvestigational

Kisspeptin-10

GnRH Stimulator · 10mg

Vial size

Status

Investigational

Route

SubQ

Half-life

~30 minutes plasma

Class

Reproductive neuropeptide

MechanismGPR54 Receptor Agonism

Cohort19 active prescriptions

Educational reference only - not a prescription or dosing recommendation. Some compounds are investigational or used off-label; suitability is a question for your own doctor. See Informed Consent & Disclaimer.

V-Series Member

$40.85 USD/vial

À-la-carte: $43 USD/vial · Save 5%

Q4 launch pricing until 31 Dec · regular $48 USD/vial from 1 Jan

Vials per allocation

Member total (1×)$40.85

À-la-carte total$43

Flat per-vial pricing. International shipping $35, free on orders of $250 or more.

What this is

Hypothalamic GnRH pulse regulator. Applications in reproductive endocrinology and HPG axis restoration protocols.

GnRH Stimulator · 10mg per vial · lot-tested.

◇

Janoshik Verified

HPLC + MS purity, every batch

Independent third-party lab

⬡

COA Per Batch

Lot-level certificates published

Labeled vs actual mg disclosed

⊙

Lot-Tested

Every lot, independent lab

Report and verification code per lot

Kisspeptin-10 · Reproductive Peptide

◆ Certificate of Analysis · Kisspeptin-10

JANOSHIK ANALYTICALHPLC + MS · Independent third-party

Lot testing in progress. The independent lab report for this Kisspeptin-10 lot will be published here, with its verification code, as soon as it is back.

◉

Clinical Overview

Kisspeptin-10

Kisspeptin-10 is a 10-amino-acid fragment of the parent kisspeptin peptide. Acts as a master regulator of the hypothalamic-pituitary-gonadal axis through GnRH neuron stimulation.

✦

Reproductive Axis

Activates KISS1R on GnRH neurons; upstream reproductive regulator.

❖

Pulsatile GnRH

Drives physiological pulsatile GnRH release.

◈

Investigational

Largely investigational for endocrine applications.

◈

Mechanism

How It Works

Activates GPR54 (KISS1R) receptors on GnRH neurons in the hypothalamus, driving pulsatile GnRH release. The natural upstream regulator of reproductive endocrinology.

Mechanism & evidence - the honest frame

Evidence frame: kisspeptin is the natural upstream trigger of the reproductive axis - it activates KISS1R on hypothalamic GnRH neurons, driving GnRH → LH/FSH → downstream testosterone/estrogen. The physiology is well-established and it is an active area of reproductive-endocrinology research (fertility, hypothalamic amenorrhoea, HPG evaluation). Honest status: human use is largely INVESTIGATIONAL - there is no approved kisspeptin product, and most data is research/early-clinical rather than large outcome trials. The theoretical concern that sustained or supraphysiologic exposure could blunt the axis (receptor desensitisation) is mechanistically plausible but not well-characterised in humans; it is a reason for physician-determined, pulsatile/cyclical use, not a self-managed protocol. Vivre presents this as endocrine-axis physiology, not a libido performance product.

✚

Patient Bloodwork Guide

Bloodwork for Cognitive & Neuro Protocols

Nootropic / neuro - Semax, Selank, DSIP, Oxytocin, PT-141, Kisspeptin

These protocols target cognition, mood, stress regulation, and sleep. Their effects are mostly subjective and behavioral, so monitoring leans on functional and stress-axis markers more than a classic blood panel - the aim is to confirm benefit without disrupting your stress hormones or sleep architecture.

Incremental approach. These are low-dose, often short-course or as-needed protocols. Vivre tracks how you actually feel and function alongside a light marker panel, rather than chasing numbers - the subjective response is the primary signal here.

Stress axis & recovery

Cortisol rhythm (AM/PM)Confirms the protocol is calming the stress axis, not over-stimulating it. The key safety/efficacy marker for this group.

HRV (heart-rate variability)A non-blood measure of nervous-system balance and recovery - rises as stress regulation improves.

Brain & vascular health

HomocysteineElevated levels are linked to cognitive risk; a useful baseline to optimize.

BDNFA marker tied to neuroplasticity - context for neuro-supportive protocols (where testing is available).

Routine safety

CBC & CMPStandard blood count, liver, and kidney panels.

When the tests happen

BaselineCortisol rhythm, HRV, homocysteine, plus how you rate mood/focus/sleep.

Month 1HRV and a subjective check-in - is it helping, any over-stimulation?

Month 3Repeat cortisol rhythm and HRV to confirm a sustained, healthy direction.

Educational only - not medical advice or a dosing instruction. Your own doctor orders tests, interprets results and decides what is right for you. See the Informed Consent & Disclaimer for full terms.

⊞

Technical Profile

Measurable Properties

Class	Kisspeptin-10 (KISS1-derived peptide)
Mechanism	KISS1R agonism; upstream stimulation of GnRH / reproductive axis - characterised
Terminal half-life	Very short (minutes)
Metabolism	Rapid peptidase degradation
Evidence base	Growing human research interest; therapeutic use investigational
Regulatory status	Investigational; research use only

Certificate of Analysis (per batch)

Analytical method: UHPLC-MS. Batch COA available on request - link to be populated per shipment.

COA link - pending per batch

Axis pharmacology characterised; therapeutic use investigational. Educational only.

Clinical Literature

Peer-Reviewed References

Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse Frequency in Men

George JT, Veldhuis JD, Roseweir AK, et al. · 2011 · Journal of Clinical Endocrinology & Metabolism 2011;96(8):E1228–E1236

▾

Findings

Kisspeptin-10 boluses potently evoke LH secretion in men (~2.5-fold rise from baseline); continuous infusion increased testosterone, LH pulse frequency and pulse size. Notably, at the physiological dose used, no desensitisation was seen over 22.5h - in contrast to higher-dose continuous primate infusions. Establishes kisspeptin as an upstream HPG-axis regulator with therapeutic potential.

View on publisher ↗

Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial

Mills EG, Ertl N, Wall MB, et al. · 2023 · JAMA Network Open 2023;6(2):e2254313

▾

Findings

Randomised, placebo-controlled crossover, 37 men with HSDD (32 completed). IV kisspeptin-54 significantly modulated brain activity in sexual-processing networks and increased penile tumescence vs placebo - without changing testosterone or cortisol in the 75-min window, supporting a central desire effect distinct from a hormonal one.

View on publisher ↗

Human kisspeptin data is real and from quality groups, but use is investigational - there is no approved kisspeptin product, the native peptide has a very short half-life (kisspeptin-10 ~minutes), and most data is acute physiological/early-clinical rather than long-term outcome trials. Vivre frames it as endocrine-axis physiology, not a libido product.

◇

Clinical Applications

Indications

HPG axis restoration following suppression
Reproductive endocrinology research
Functional hypogonadism evaluation
Specialized fertility research contexts

⊙

Pharmacokinetics

Half-Life & Duration of Action

Half-life is how long a compound stays at active plasma concentration in your body. Most peptides in this catalogue have short plasma half-lives - they clear from your bloodstream within hours, sometimes minutes. The long-half-life compounds in this catalogue are the approved-class incretins (Tirzepatide, Semaglutide, Retatrutide), which are designed for once-weekly dosing - that's the molecular engineering choice that makes weekly dosing work.

Plasma Half-Life

~30 minutes plasma. Diagnostic protocols use bolus dosing; therapeutic protocols use pulsatile or sustained dosing.

Why this matters for you

If you don't tolerate a compound or need to discontinue a protocol, short-half-life peptides are out of your bloodstream within hours - not days or weeks. That said, the biological effects they initiate (tissue repair signalling, mitochondrial signalling, gene expression changes) often persist longer than the peptide itself, through downstream cellular cascades. This is normal peptide pharmacology and is important context - the molecule clears fast, but the biology takes longer to wind down.

Evidence Base

Active clinical research area. Use is specialized.

Dosing protocols, administration frequency, and titration schedules are not published on these public pages.

FOR CUSTOMERS

Mixing guide and dosage calculator

Unlocks once you order Kisspeptin-10: step-by-step mixing with illustrations, storage, and a calculator that converts any dose to syringe units at your vial strength.

READY TO PROCEED

Start with the Biological Audit

Kisspeptin-10 is verified and lot-tested, dispensed following a Biological Audit. The Audit is complimentary for the Batch 001 cohort.

$40.85 USD/vial

Kisspeptin-10 · Member rate